MCF 10A Cells Complete Medium
Cat.No.:CM-0525
| Item | Size | Price | Qty |
|---|---|---|---|
| 125mL×4 | Inquire |
Product Introduction
MCF 10A Cell Complete Medium is a ready-to-use medium that can be directly used for the culture of MCF 10A cell
Matters Need Attention
1. This product is for research use only.
2. This product is sterilized by 0.1μm filtration.
3. It is necessary to pay attention to the aseptic operation and avoid the contamination during the culture.
4. It is not suitable for long time storage at room temperature.
5. This product is a ready-to-use medium. If there is no special need, don’t add serum, penicillin and streptomycin. It can be used directly.
| Specifications | |
| Concentration | Ready-to-use |
| Volume | 125mL×4 |
| Form | Liquid |
| Bacteria Detection | Negative |
| Fungi Detection | Negative |
| Mycoplasma Detection | Negative |
| Endotoxin Content | <3 |
| pH | 7.4-7.8 |
| Green_Features | Sustainable packaging |
| Valid Period | 3 months |
| Storage Condition | 2~8℃, shading light |
| Shipping Condition | Ice bag |
Related Products
Documents
Citations
Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors via the transporter ASCT2
IF: 7.571Author：Ping Zhou, Xingmei Liang, Ce Zhou
Journal：Journal of Materials Chemistry B
Cited products： CM-0525
Glucose oxidase and polydopamine functionalized iron oxide nanoparticles: combination of the photothermal effect and reactive oxygen species generation for dual-modality selective cancer therapy
IF: 7.571Author：Tiantian Zhang, Yinping Li, Weiying Hong
Journal：Journal of Materials Chemistry B
Cited products： CM-0525
miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer
IF: 9.685Photothermally triggered cytosolic drug delivery of glucose functionalized polydopamine nanoparticles in response to tumor microenvironment for the GLUT1-targeting chemo-phototherapy
IF: 11.467Author：Yinping Li, Weiying Hong, Henan Zhang
Journal：Journal of Controlled Release
DOI：10.1016/j.jconrel.2019.11.031
Cited products： CM-0525
Determination of lipid mediators in breast cancer cells using lyophilization‒supercritical fluid extraction online coupled with supercritical fluid chromatography‒quadrupole tandem mass spectrometry
IF: 3.614Author：Fengying Ye, Qisheng Zhong, Yanshan Liang
Journal：Journal of Separation Science
Cited products： CM-0525
miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3
IF: 7.634MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor
IF: 9.685Author：Xiaochong Deng, Danrong Ye, Kaiyao Hua
Journal：Cell Death & Disease
DOI：10.1038/s41419-021-04105-9
Cited products： CM-0525
Luminescent Silica Nanosensors for Lifetime Based Imaging of Intracellular Oxygen with Millisecond Time Resolution
IF: 8.008Author：Longjiang Ding, Wei Zhang, Yinglu Zhang
Journal：Anal Chem
DOI：10.1021/acs.analchem.9b03726
Cited products： CM-0525
GABAB1e promotes the malignancy of human cancer cells by targeting the tyrosine phosphatase PTPN12
IF: 6.107Author：Bo Wei, Yini Zhu, Peng Yang
Journal：iScience
DOI：10.1016/j.isci.2021.103311
Cited products： CM-0525
Copper Tannic Acid-Coordinated Metal–Organic Nanosheets for Synergistic Antimicrobial and Antifouling Coatings
IF: 10.383Author：Yilong Liu, Rui Su, Juan Song
Journal：ACS Applied Materials & Interfaces
Lysophosphatidic acid receptor 6 regulated by miR-27a-3p attenuates tumor proliferation in breast cancer
IF: 3.34Author：J Lei, S Guo, K Li
Journal：Clinical & Translational Oncology
DOI：10.1007/s12094-021-02704-8
Cited products： CM-0525
MAPK4 silencing together with a PARP1 inhibitor as a combination therapy in triple‑negative breast cancer cells
IF: 3.423Author：Xiaoqi Zeng, Shanshan Jiang, Simin Ruan
Journal：Molecular Medicine Reports
Cited products： CM-0525
miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3
IF: 7.634The functions and prognostic value of Krüppel‐like factors in breast cancer
IF: 6.429Author：Keyun Zhu, Yao Tian, Yingxi Li
Journal：Cancer Cell International
DOI：10.1186/s12935-022-02449-6
Cited products： CM-0525
